Gabelli & Co Investment Advisers’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-179,375
Closed -$7.22M 196
2016
Q3
$7.22M Buy
+179,375
New +$4.43M 0.84% 34

Gabelli & Co Investment Advisers's CYNA Position: Q4 2016 in Review

Gabelli & Co Investment Advisers sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 179,375 shares — an estimated $7.22M sold.

Gabelli & Co Investment Advisers first reported a position in CYNA in Q3 2016 and held it in 1 quarter. The position peaked at $7.22M in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

  • Gabelli & Co Investment Advisers reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 179,375 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $7.22M.
  • Gabelli & Co Investment Advisers first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q3 2016 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $7.22M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2016, filed 10 Feb 2017.